Skip to main content

BGB Group Acquires Hayden Consulting Group to Bolster Market Access and Patient Services

Written by Customer Service on . Posted in Mergers And Acquisitions.

Expansion of BGB’s Strategic Advisory practice provides breakthrough commercial solutions across pharma’s full portfolio and brand lifecycles

  • Premier Market & Patient Access: Hayden is renowned for resolving the industry’s most complex payer, reimbursement, and affordability obstacles for global brands.
  • Expansive Advisory Practice: BGB Strategic Advisory practice provides breakthrough solutions across commercial portfolios and brand lifecycles from Commercial Due Diligence, New Product Planning, Go-to-Market Strategies, and Market Access and Patient Services Strategic Consulting.
  • Advisory & Communications: BGB Group’s combined Strategic Advisory and Communications offerings help brand teams realize their full commercial potential through one connected partner.

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — BGB Group, a leading commercial solutions company that delivers breakthrough strategies and execution for biopharmaceutical companies, today announced it has acquired Hayden Consulting Group, a premier market access and patient services consultancy renowned for resolving complex payer, reimbursement, and affordability obstacles.

By uniting Hayden’s demonstrated market access and patient services expertise with BGB’s Strategic Advisory services, clients gain a more comprehensive offering to navigate challenges across the full portfolio and brand lifecycle, from Commercial Due Diligence and New Product Planning to Go-to-Market Strategy and Market Access and Patient Services. Together with BGB’s Medical Communications and Advertising services, clients now have one connected partner to address access barriers, manage launch complexities, and realize their full commercial potential.

“In an industry where regulatory shifts and economic pressures can sideline promising therapies, this acquisition is a game-changer for our clients,” said David Coman, Chief Executive Officer of BGB Group. “Hayden’s market access expertise naturally aligns with BGB’s capabilities and elevates BGB’s ability to guide the full commercial journey, delivering the clarity and strategic rigor needed in today’s complex ecosystem of care.”

Hayden will continue to be led by co-founders Jamie Sidore and David MacDougall, and will become part of BGB’s Strategic Advisory practice, which is led by Hilary Gentile, Chief of Commercial Strategy and Innovation.

“Joining BGB propels Hayden to new heights,” said Dave MacDougall, Managing Director and Co-Founder of Hayden Consulting Group. “Our clients demand market access strategies that are seamlessly embedded as part of their commercialization plan and not as an afterthought. The combined company scales that vision, delivering value that transforms challenges into opportunities of growth for our customers.”

Jamie Sidore, Managing Director and Co-Founder of Hayden Consulting Group added, “By joining forces with BGB Group, Hayden can offer clients integrated solutions that span New Product Planning to Commercialization and Launch Execution – from our existing Access, Affordability and Patient Services capabilities – all the way through to the execution of Communications and Advertising. The combined businesses truly represent industry-leading capabilities under one roof.”

Since partnering with global alternative asset management firm TPG, BGB has expanded its leadership in Medical Communications and Advertising while strategically adding complementary capabilities in data/analytics, consulting, strategy advisory services, and market access through organic growth and selective acquisitions.

For more on how this strengthens life sciences commercialization, follow BGB Group on LinkedIn.

Financial terms were not disclosed. MP Law LLC served as legal counsel for BGB Group. Clearsight Advisors served as the exclusive financial advisor, and Morgan, Lewis & Bockius LLP served as legal counsel for Hayden Consulting Group.

About BGB Group
BGB Group is a commercial solutions company that partners with pharmaceutical, biotech, and medical device companies to navigate complex challenges. With integrated capabilities, including strategic advisory, market access, medical communications, and advertising, and a commitment to client success, BGB Group helps clients achieve meaningful outcomes that improve patient lives. Learn more at bgbgroup.com.

Media Inquiries
Terry Rehm
trehm@bgbgroup.com
 862-288-0329

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.